Hims & Hers Health, Inc.
HIMS
$39.76
$1.363.54%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 78.02% | 88.69% | 85.99% | 69.33% | 56.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 78.02% | 88.69% | 85.99% | 69.33% | 56.70% |
| Cost of Revenue | 135.76% | 152.14% | 142.69% | 93.17% | 56.90% |
| Gross Profit | 64.59% | 74.94% | 73.88% | 64.09% | 56.66% |
| SG&A Expenses | 57.34% | 60.85% | 56.92% | 48.46% | 39.76% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 74.76% | 78.95% | 73.03% | 57.07% | 43.81% |
| Operating Income | 162.69% | 766.83% | 2,319.30% | 353.75% | 217.93% |
| Income Before Tax | 147.72% | 559.65% | 23,253.41% | 432.44% | 248.34% |
| Income Tax Expenses | 88.06% | -1,909.95% | -1,656.98% | -2,850.73% | -5,597.45% |
| Earnings from Continuing Operations | 32.13% | 969.45% | 7,092.56% | 635.28% | 383.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 32.13% | 969.45% | 7,092.56% | 635.28% | 383.65% |
| EBIT | 162.69% | 766.83% | 2,319.30% | 353.75% | 217.93% |
| EBITDA | 173.61% | 498.17% | 2,546.13% | 603.75% | 297.95% |
| EPS Basic | 28.13% | 947.62% | 6,218.70% | 614.87% | 372.93% |
| Normalized Basic EPS | 136.18% | 480.00% | 3,538.78% | 500.73% | 259.52% |
| EPS Diluted | 25.12% | 969.75% | 4,340.74% | 572.02% | 351.63% |
| Normalized Diluted EPS | 129.08% | 475.59% | 4,803.03% | 462.93% | 247.49% |
| Average Basic Shares Outstanding | 4.14% | 3.79% | 3.40% | 3.16% | 2.94% |
| Average Diluted Shares Outstanding | 7.79% | 9.27% | 10.05% | 10.90% | 10.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |